Aug 29, 2024

Featuring a slide presentation and related discussion from Dr Priyanka Sharma, including the following topics:

• Biomarker Assays in the Identification and Prognostication of Patients with Breast Cancer (0:00)
• Utility of Circulating Tumor DNA in the Prognostication of Localized Breast Cancer (24:28)
• Treatment of HR-Positive, HER2-Negative Advanced Breast Cancer with a PI3K Mutation (29:46)
• Utility of Subsequent CDK4/6 Inhibitor After Disease Progression on Initial Therapy (34:57)
• Treatment of HER2-Low or HER2-Ultralow Metastatic Breast Cancer (40:59)
• Updated Data and Novel Strategies Involving Trastuzumab Deruxtecan for the Treatment of Advanced Breast Cancer (49:42)
• Oral Selective Estrogen Receptor Degraders for the Treatment of ER-Positive, HER2-Positive Breast Cancer (51:55)
• Novel Strategies Involving Antibody-Drug Conjugates and Immunotherapy for Triple-Negative Breast Cancer (58:12)

CME information and select publications